ImmunityBio Inc. Common Stock vs iShares 0 3 Month Treasury Bond ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while iShares 0 3 Month Treasury Bond ETF trades at $100.51 (market cap $114.04B). The key difference: iShares 0 3 Month Treasury Bond ETF is far larger — about 11× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares 0 3 Month Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and iShares 0 3 Month Treasury Bond ETF for 50 Days on average.
| IBRX | SGOV | |
|---|---|---|
Market Cap | $10.33B | $114.04B |
Volume | 11,745,198 | 19,563,576 |
Sector | Health | Fixed Income |
52-Week High | $11.55 | $100.72 |
52-Week Low | $1.98 | $100.28 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $10.79B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SGOV (iShares 0-3 Month Treasury Bond ETF) trades at $100.465 with minimal daily movement, reflecting its stable Treasury bill focus. The ETF shows bearish technical signals with 17 sell indicators versus 4 buys, though RSI levels suggest potential oversold conditions. Recent institutional selling by Envestnet Asset Management (-13.2% in Q2 2026) contrasts with consistent dividend distributions around $0.30-0.31 monthly.
SGOV provides stable income exposure to short-term US Treasuries amid rising bond yields, but faces headwinds from the ongoing bond market rout. The ETF's defensive positioning appeals to income-focused investors, though continued yield increases could pressure near-term performance. Current technical weakness suggests cautious entry points may emerge.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →